IPP Bureau
Tagrisso recommended for approval in the EU for unresectable EGFR-mutated lung cancer
By IPP Bureau - November 19, 2024
Recommendation based on LAURA Phase III trial results which showed Tagrisso extended median progression-free survival to more than three years
Sanofi invests €40 million to strengthen antibody bioproduction in France
By IPP Bureau - November 19, 2024
Blenrep shows overall survival benefit in DREAMM-7 phase III trial for relapsed/refractory multiple myeloma
By IPP Bureau - November 19, 2024
Statistically significant and clinically meaningful reduction in the risk of death seen with Blenrep (belantamab mafodotin) plus bortezomib and dexamethasone (BorDex) versus daratumumab plus BorDex
.jpg "Emcure Pharmaceuticals teams up with MS Dhoni to bat for stroke awareness")
Emcure Pharmaceuticals teams up with MS Dhoni to bat for stroke awareness
By IPP Bureau - November 17, 2024
Emcure and Dhoni, through a video, urge everyone to be aware about symptoms of stroke and educate at least one person for identification of stroke and spread its awareness
Wanbury Q2 FY25 revenue at Rs. 161.2 crore, up 11.6%
By IPP Bureau - November 16, 2024
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
Zota Health Care Q2 FY25 revenue up 48.6%
By IPP Bureau - November 16, 2024
Gross Profit stood at Rs. 36.02 crore compared to Rs. 20.42 crore during Q2FY24, a significant increase of 76.40%
Natco Pharma appoints Madhava Rao Karicherla as Associate VP – Formulation Research & Development
By IPP Bureau - November 16, 2024
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
Ecovyst launches AlphaCat advanced silicas products for biocatalysis applications
By IPP Bureau - November 16, 2024
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
Univar Solutions becomes exclusive distributor of SD Head USA Pharmaceutical excipients in North America
By IPP Bureau - November 16, 2024
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
USFDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
By IPP Bureau - November 16, 2024
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
IOL Chemicals and Pharmaceuticals posts Q2 FY25 PT at Rs. 19 Cr
By IPP Bureau - November 16, 2024
Total Income in Q2 FY25 stood at Rs. 532.18 crore
Merck receives positive EU CHMP opinion for pembrolizumab plus chemotherapy as first-line treatment for unresectable non-epithelioid MPM
By IPP Bureau - November 16, 2024
Opinion granted based on positive overall survival results from the IND.227/KEYNOTE-483 trial
Lubrizol and Polyhose ink MoU to set up medical tube manufacturing facility in Tamil Nadu
By IPP Bureau - November 15, 2024
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Shilpa Medicare Q2 FY25 consolidated PAT up 1,008% at Rs. 18 Cr
By IPP Bureau - November 15, 2024
NABH integrates FOGSI’S maternal health standards across its certification programs
By IPP Bureau - November 15, 2024
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
